SCHEMBL5784671

SCHEMBL5784671

COc1cc(NC(C)=O)ccc1C(C)=O.COc1cccc(NC(C)=O)c1

nearest known ligand 0.64

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 2/20 0.64
MTNR1B P49286 2/20 0.64
POLB P06746 1/20 0.62
TSHR P16473 2/20 0.61
MAPK1 P28482 1/20 0.61
NPC1 O15118 5/20 0.60
RAB9A P51151 5/20 0.60
TP53 P04637 3/20 0.60
SMN1; SMN2 Q16637 2/20 0.60
KMT2A Q03164 3/20 0.56
PKM P14618 2/20 0.56
MEN1 O00255 2/20 0.56
MAPT P10636 1/20 0.56
RXFP1 Q9HBX9 1/20 0.56
ALDH1A1 P00352 2/20 0.56
NLRP3 Q96P20 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1493992 0.89 MAPK1 (0.57) POLBMAPK1NPC1RAB9ATP53
SCHEMBL5784679 0.88 MTNR1B (0.58) MTNR1AMTNR1BPOLBNPC1RAB9A
SCHEMBL171425 0.85 MTNR1A (0.79) MTNR1AMTNR1BPOLBTSHRNPC1
SCHEMBL29875454 0.85 MTNR1A (0.79) MTNR1AMTNR1BPOLBTSHRNPC1
Acetic Acid SCHEMBL28264765 0.82 MTNR1A (0.74) MTNR1AMTNR1BTSHRNPC1RAB9A
SCHEMBL9306299 0.80 TSHR (0.71) MTNR1AMTNR1BTSHRMAPK1NPC1
SCHEMBL1162352 0.78 TDP1 (0.56) POLBMAPK1SMN1; SMN2KMT2AMEN1
SCHEMBL2555975 0.78 TDP1 (0.73) POLBMAPK1SMN1; SMN2KMT2AMEN1
SCHEMBL10811158 0.77 MTNR1A (0.67) MTNR1AMTNR1BTSHRNPC1RAB9A
SCHEMBL12970763 0.77 TDP1 (0.55) POLBMAPK1NPC1RAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1725540-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F.HOFFMANN-LA ROCHE AG (CH) 2006-11-29 EP disclosed
WO-2005095359-A1 DIAMINOPYRIMIDINES AS P2X3 AND P2X2/3 ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2005-10-13 WO disclosed